DRAGASAC LIMITED
Dragasac Limited is a wholly-owned subsidiary of Malaysian investment holding company Genting Berhad.
DRAGASAC LIMITED
Industry:
Banking Financial Services
Address:
Ladang West Country, Selangor, Malaysia
Country:
Malaysia
Status:
Active
Similar Organizations
Prime Exchange
Prime Exchange is a fully owned exchange company in Singapore.
Yuanta Securities
Yuanta Securities is a wholly-owned subsidiary of Yuanta Financial Holdings.
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2021-07-19 | Celularity | Dragasac Limited investment in Post-IPO Equity - Celularity | 80 M USD |
| 2017-08-18 | HealthLytix | Dragasac Limited investment in Seed Round - HealthLytix | 4 M USD |
| 2014-03-18 | CorTechs Labs | Dragasac Limited investment in Series B - CorTechs Labs | N/A |
More informations about "Dragasac Limited"
Dragasac Limited - Crunchbase Company Profile & Funding
Organization. Dragasac Limited . Connect to CRM . Save . Summary. Financials. People. …See details»
Dragasac Limited - Funding, Financials, Valuation & Investors
Jul 19, 2021 Dragasac Limited 's most notable exits include Celularity and HealthLytix. Which …See details»
Celularity and Genting Leaders Comments on Closing $21 Million ...
Jan 25, 2024 Celularity closed two financing transactions on January 16, 2024, totaling $21 …See details»
SEC.gov | HOME
CITIZENSHIP OR PLACE OF ORGANIZATION ... This amount includes 6,529,818 Common …See details»
SEC.gov | HOME
2. Calculation is based on the sum of (i) 193,781,641 Common Shares outstanding as of …See details»
Celularity and Genting Leaders Comments on Closing $21 Million ...
Jan 25, 2024 As detailed in the Form 8-K filed by the Company, one of the two financing …See details»
Celularity and GX Acquisition Corp. Announce Merger Agreement …
Celularity stockholders (including Sorrento Therapeutics, affiliates of Bristol Myers Squibb, …See details»
Celularity and Genting Leaders Comments on Closing $21 Million ...
Jan 25, 2024 As detailed in the Form 8-K filed by the Company, one of the two financing …See details»
Dragasac Limited - Crunchbase
Dragasac Limited is a wholly-owned subsidiary of Malaysian investment holding company …See details»
Cortechs.ai and HealthLytix announce merger - Cortechs.ai
Jun 9, 2020 The company’s primary investor is Dragasac Limited, a subsidiary of leading …See details»
Celularity and GX Acquisition Corp. Announce Merger Agreement …
Jan 8, 2021 - Celularity stockholders (including Sorrento Therapeutics, affiliates of Bristol …See details»
DRAGASAC LIMITED :: Isle of Man :: OpenCorporates
Recent filings for dragasac limited. 1 jun 2015. annual return. 27 nov 2014. change in register of …See details»
Celularity and Genting Leaders Comments on Closing $21
Jan 25, 2024 Celularity closed two financing transactions on January 16, 2024, totaling $21 …See details»
Celularity to Go Public Through SPAC Merger - Cooley
Jan 13, 2020 Celularity stockholders, including Sorrento Therapeutics, affiliates of Bristol …See details»
Dragasac Limited - Updates, News, Events, Signals & Triggers
Dragasac Limited is a wholly-owned subsidiary of Malaysian investment holding company …See details»
Celularity and GX Acquisition announce merger agreement to …
Celularity, a clinical-stage biotechnology company, leading the next evolution in cellular …See details»
Cortechs.ai secures Series B investment led by Genting Berhad
SAN DIEGO, March 18, 2014 — Medical software developer Cortechs.ai, Inc. (CorTechs) is …See details»
Celularity Inc. announced that it expects to receive $6 million in ...
Jan 11, 2024 Celularity Inc. announced that it has entered into a securities purchase …See details»
Dragasac Ltd - Activist 13D/13G Filings - Fintel
This page shows a list of all the recent 13D/G filings made by Dragasac Ltd. Schedule 13D is …See details»
Celularity and GX Acquisition Corp. Announce Merger Agreement …
Jan 8, 2021 Investors in the PIPE include existing Celularity stockholders or their affiliates …See details»